1.Changes in Medical Practice Pattern before and after Covering Intraocular Lens in the Health Insurance.
No Ah CHOI ; Seung Hum YU ; Hey Young MIN ; Eun Wook CHUNG
Korean Journal of Preventive Medicine 1994;27(4):807-814
This study is to find out changes in medical practice at a university hospital before and after covering intraocular lens (IOL) from the health insurance benefit. The coverage started on March 1, 1993 and a total of 596 cases who were discharged from July 1 to December 31, 1992 and 580 cases who were discharged from July 1 to December 31, 1993 were analyzed. Since the standard reimbursement scheme was changed from March 1, 1993, the charges for 1992 were transformed into 1993 scheme. Major findings are as follows: Average length of stay was statistically significantly decreased from 8.24 days in 1992 to 6 86 days in 1993. Charges except IOL has been statistically significantly decreased from 501,000 won in 1992 to 444,000 won in 1993. Charges for drugs and injection have been reduced. However, charge per day for them was not much different. This is due to decrease in length of stay. Charges for laboratory tests and radiologic examination were quite the same. charges which are not covered by the insurance remained the same. The revenue of the hospital was reduced as expected. However, the hospital reduced the length of stay and increase the turnover rate in order to compensate the potential loss of revenue due to the difference of reimbursement between the out-of-pocket expense and the insurance coverage. By introducing the IOL benefit in the insurance, the insured pays less, hospital generates more revenue through shortening the hospital stay, and the total medical care cost becomes less nationwidely.
Health Care Costs
;
Insurance
;
Insurance Coverage
;
Insurance, Health*
;
Length of Stay
;
Lenses, Intraocular*
2.Antibacterial and therapeutic effects of a combination of Sophora flavescens and Glycyrrhiza uralensis Fischer ethanol extracts on mice infected with Streptococcus pyogenes.
Eun Ah YU ; Chun Nam CHA ; Eun Kee PARK ; Chang Yeul YOO ; Suk KIM ; Hu Jang LEE
Korean Journal of Veterinary Research 2014;54(3):189-192
This study evaluated the antibacterial effects of a mixture of Sophorae radix and Glycyrrhiza uralensis Fischer (1 : 1) ethanol extracts (SGE) on mice infected with Streptococcus (S.) pyogenes. The minimum inhibitory concentration (MIC) and minimum bactericidal concentration of SGE necessary for antibacterial effects against S. pyogenes were 20 microg/mL. Based on the time-kill curves for S. pyogenes, SGE was effective at 4x MIC after 16 h. On Day 12 after challenge, the survival rate of mice treated with 2.0 mg/kg SGE was 60%. In conclusion, SGE had potent in vitro and in vivo antibacterial activities against S. pyogenes.
Animals
;
Complex Mixtures
;
Ethanol*
;
Glycyrrhiza uralensis*
;
Mice*
;
Microbial Sensitivity Tests
;
Plants, Medicinal
;
Sophora*
;
Streptococcus
;
Streptococcus pyogenes*
;
Survival Rate
;
Treatment Outcome
3.Antibacterial and therapeutic effects of a combination of Sophora flavescens and Glycyrrhiza uralensis Fischer ethanol extracts on mice infected with Streptococcus pyogenes.
Eun Ah YU ; Chun Nam CHA ; Eun Kee PARK ; Chang Yeul YOO ; Suk KIM ; Hu Jang LEE
Korean Journal of Veterinary Research 2014;54(3):189-192
This study evaluated the antibacterial effects of a mixture of Sophorae radix and Glycyrrhiza uralensis Fischer (1 : 1) ethanol extracts (SGE) on mice infected with Streptococcus (S.) pyogenes. The minimum inhibitory concentration (MIC) and minimum bactericidal concentration of SGE necessary for antibacterial effects against S. pyogenes were 20 microg/mL. Based on the time-kill curves for S. pyogenes, SGE was effective at 4x MIC after 16 h. On Day 12 after challenge, the survival rate of mice treated with 2.0 mg/kg SGE was 60%. In conclusion, SGE had potent in vitro and in vivo antibacterial activities against S. pyogenes.
Animals
;
Complex Mixtures
;
Ethanol*
;
Glycyrrhiza uralensis*
;
Mice*
;
Microbial Sensitivity Tests
;
Plants, Medicinal
;
Sophora*
;
Streptococcus
;
Streptococcus pyogenes*
;
Survival Rate
;
Treatment Outcome
4.The Effect of an Angiotensin Receptor Blocker on Arterial Stiffness in Type 2 Diabetes Mellitus Patients with Hypertension.
Ji Hyun KIM ; Su Jin OH ; Jung Min LEE ; Eun Gyoung HONG ; Jae Myung YU ; Kyung Ah HAN ; Kyung Wan MIN ; Hyun Shik SON ; Sang Ah CHANG
Diabetes & Metabolism Journal 2011;35(3):236-242
BACKGROUND: Hypertension and type 2 diabetes mellitus are major risk factors for cardiovascular disease. This study analyzed the changes in central aortic waveforms and pulse wave velocity as well as related parameters after treatment with valsartan, an angiotensin II type 1 receptor blocker, in patients with type 2 diabetes and hypertension. METHODS: We used pulse wave analysis to measure central aortic waveform in a total of 98 subjects. In 47 of these patients, pulse wave velocity measurements were obtained before and after 12 weeks of treatment with valsartan. RESULTS: In the central aortic waveform analysis, the aortic pulse pressure and augmentation index were significantly decreased after valsartan treatment, as was the aortic pulse wave velocity. Factors contributing to the improvement in pulse wave velocity were the fasting blood glucose and haemoglobin A1c levels. CONCLUSION: Short-term treatment with valsartan improves arterial stiffness in patients with type 2 diabetes and hypertension, and the glucose status at baseline was associated with this effect.
Angiotensins
;
Arterial Pressure
;
Blood Glucose
;
Cardiovascular Diseases
;
Diabetes Mellitus
;
Diabetes Mellitus, Type 2
;
Fasting
;
Glucose
;
Humans
;
Hypertension
;
Pulse Wave Analysis
;
Receptor, Angiotensin, Type 1
;
Risk Factors
;
Tetrazoles
;
Valine
;
Vascular Stiffness
;
Valsartan
5.Response: The Effect of an Angiotensin Receptor Blocker on Arterial Stiffness in Type 2 Diabetes Mellitus Patients with Hypertension (Diabetes Metab J 2011;35:236-42).
Ji Hyun KIM ; Su Jin OH ; Jung Min LEE ; Eun Gyoung HONG ; Jae Myung YU ; Kyung Ah HAN ; Kyung Wan MIN ; Hyun Shik SON ; Sang Ah CHANG
Diabetes & Metabolism Journal 2011;35(4):429-430
No abstract available.
Angiotensins
;
Diabetes Mellitus, Type 2
;
Humans
;
Hypertension
;
Vascular Stiffness
6.Non-invasive prediction of post-sustained virological response hepatocellular carcinoma in hepatitis C virus: A systematic review and meta-analysis
Han Ah LEE ; Mi Na KIM ; Hye Ah LEE ; Miyoung CHOI ; Jung Hwan YU ; Young-Joo JIN ; Hee Yeon KIM ; Ji Won HAN ; Seung Up KIM ; Jihyun AN ; Young Eun CHON
Clinical and Molecular Hepatology 2024;30(suppl):s172-s185
Background:
s/Aims: Despite advances in antiviral therapy for hepatitis C virus (HCV) infection, hepatocellular carcinoma (HCC) still develops even after sustained viral response (SVR) in patients with advanced liver fibrosis or cirrhosis. This meta-analysis investigated the predictive performance of vibration-controlled transient elastography (VCTE) and fibrosis 4-index (FIB-4) for the development of HCC after SVR.
Methods:
We searched PubMed, MEDLINE, EMBASE, and the Cochrane Library for studies examining the predictive performance of these tests in adult patients with HCV. Two authors independently screened the studies’ methodological quality and extracted data. Pooled estimates of sensitivity, specificity, and area under the curve (AUC) were calculated for HCC development using random-effects bivariate logit normal and linear-mixed effect models.
Results:
We included 27 studies (169,911 patients). Meta-analysis of HCC after SVR was possible in nine VCTE and 15 FIB-4 studies. Regarding the prediction of HCC development after SVR, the pooled AUCs of pre-treatment VCTE >9.2–13 kPa and FIB-4 >3.25 were 0.79 and 0.73, respectively. VCTE >8.4–11 kPa and FIB-4 >3.25 measured after SVR maintained good predictive performance, albeit slightly reduced (pooled AUCs: 0.77 and 0.70, respectively). The identified optimal cut-off value for HCC development after SVR was 12.6 kPa for pre-treatment VCTE. That of VCTE measured after the SVR was 11.2 kPa.
Conclusions
VCTE and FIB-4 showed acceptable predictive performance for HCC development in patients with HCV who achieved SVR, underscoring their utility in clinical practice for guiding surveillance strategies. Future studies are needed to validate these findings prospectively and validate their clinical impact.
7.Incidence and Risk Factors of Rehospitalization with Respiratory Syncytial Virus Infection in Premature Infants.
Eun Ah LEE ; Jea Heon JEONG ; Seung Taek YU ; Chang Woo LEE ; Hyang Suk YOON ; Do Sim PARK ; Yeon Kyun OH
Korean Journal of Pediatrics 2004;47(5):510-514
PURPOSE: We performed this study to evaluate the risk of rehospitalization for respiratory syncytial virus(RSV) infection among premature infants discharged from a neonatal intensive care unit(NICU). METHODS: We performed a retrospective study for rehospitalization for RSV infection and risk factors among premature infants who were admitted to NICU and discharged between May 2001 and April 2003 in Wonkwang University Hospital. RSV detection was utilized by direct fluorescent antibody tests in nasopharyngeal aspirates. We also reviewed various risk factors including gestational age, birth weight, sex, ventilatory care, surfactant administration, chronic lung disease(CLD), siblings in school or kindergarten age, and month of discharge. RESULTS: The rehospitalization rate for RSV infection was 6.6%(26/381) in premature infants and 22.2%(4/18) in premature infants with CLD. The most common season of rehospitalization for RSV infection was between November to January, this was 69.2%(18/26) in premature infants, the same as children: 61.2%(93/152). The risk factors for RSV rehospitalization among premature infants were CLD, siblings in school or kindergarten age and discharge between October to December from NICU. CONCLUSION: The risk for RSV rehospitalization among premature infants from NICU was low. Preterm infants subject to risk factors of CLD, siblings in school or kindergarten age, and discharge between October to December from NICU, were most likely to require hospitalization for RSV disease. In CONCLUSION: Prophylaxis for RSV infection should be considered one month before discharge from NICU in the RSV season between October and December.
Birth Weight
;
Child
;
Gestational Age
;
Hospitalization
;
Humans
;
Incidence*
;
Infant, Newborn
;
Infant, Premature*
;
Intensive Care, Neonatal
;
Lung
;
Respiratory Syncytial Viruses*
;
Retrospective Studies
;
Risk Factors*
;
Seasons
;
Siblings
8.Congenital Heart Disease: a Pictorial Illustration of Putting Segmental Approach into Practice.
Tse Hang YEUNG ; Eun Ah PARK ; Ying Cheong LEE ; Jin Young YOO ; Choi Yu LUI
Investigative Magnetic Resonance Imaging 2015;19(4):205-211
The human heart is a complex organ in which many complicated congenital defects may happen and some of them require surgical intervention. Due to the vast complexity of varied anatomical presentations, establishing an accurate and consistent nomenclature system is utmost important to facilitate effective communication among pediatric cardiologists, cardiothoracic surgeons and radiologists. The Van Praagh segmental approach to the complex congenital heart disease (CHD) was developed in the 1960s and has been used widely as the language for describing complex anatomy of CHD over the decades. It utilizes a systematic and sequential method to describe the cardiac segments and connections which in turn allows accurate, comprehensive and unambiguous description of CHD. It can also be applied to multiple imaging modalities such as echocardiogram, cardiac CT and MRI. The Van Praagh notation demonstrates a group of three letters, with each letter representative for a key embryologic region of cardiac anatomy: the atria, ventricles and great vessels. By using a 3-steps approach, we can evaluate complex CHD precisely and have no difficulties in communicating with other medial colleague. This pictorial essay revisits the logical steps of segmental approach, followed by a pictorial illustration of its application.
Congenital Abnormalities
;
Heart
;
Heart Defects, Congenital*
;
Humans
;
Logic
;
Magnetic Resonance Imaging
9.Idiopathic Pulmonary Fibrosis with Coexisting Emphysema: High-Resolution CT and Clinical Correlation.
Eun Young KANG ; Kyeong Ah KIM ; Yu Whan OH ; Jae Jeong SHIM ; Kyung Ho KANG
Journal of the Korean Radiological Society 1997;36(5):761-766
PURPOSE: To correlate high-resolution CT (HRCT) findings with smoking history and pulmonary function test (PFT) in patients with idiopathic pulmonary fibrosis (IPF) with or without coexisting emphysema. MATERIALS AND METHODS: The study included 24 patients who had undergone HRCT and in whom IPF had been confirmed pathologically (n=7) and clinically (n=17). The patients included 19 men and 5 women aged between from 44 and 78 (mean 59) years. HRCT findings were reviewed by two radiologists and assessed for the presence and extent of emphysema (CT emphysema score ; CES) and honeycombing (CT honeycombing score ; CHS). CES and CHS were retrospectively correlated with smoking status and pulmonary function test. RESULTS: Evidence of emphysema was seen on HRCT in 20 of 24 patients with IPF (83 %). CES was 14.3 and CHS was 18.1 in smokers with IPF, as compared with 1.8 and 6.7 in nonsmokers (p < 0.01). Pulmonary function tests showed lower percent predicted FEV1 (69.3 %), FVC (64.7 %), TLC(73.7 %), and RV (77.3 %), a lower percent predicted diffusing capacity of carbon monoxide (58.2%), and normal FEV1/FVC (99.1%). The pulmonary function test in smokers showed higher TLC and RV than in nonsmokers. Eight of nine patients whose CES was higher than their CHS, as seen on HRCT, were smokers and had a smoking history of 33.1 pack-years. Seven of 15 whose CHS was higher than their CES were smokers and had a smoking history of 16.8 pack-years. In patients with a higher CES than CHS pulmonary function test results showed normal TLC (85 %) and RV (100.7%) ; this contrasted with decreased TLC (72 %) and RV (68 %) in patients whose CHS was higher than their CES. CONCLUSION: Emphysema is a frequently associated finding in patients with IPF, as seen on HRCT, and emphysema is more frequent and extensive in smokers with IPF than non-smokers. HRCT is useful for detecting emphysema in patients with IPF, and the extent of emphysema on HRCT correlates with the results of the pulmonary function test and smoking status.
Carbon Monoxide
;
Emphysema*
;
Female
;
Humans
;
Idiopathic Pulmonary Fibrosis*
;
Male
;
Respiratory Function Tests
;
Retrospective Studies
;
Smoke
;
Smoking
10.Overexpression of Human Arginine Decarboxylase Rescues Human Mesenchymal Stem Cells against H2O2 Toxicity through Cell Survival Protein Activation.
Su Kyoung SEO ; Wonsuk YANG ; Yu Mi PARK ; Won Taek LEE ; Kyung Ah PARK ; Jong Eun LEE
Journal of Korean Medical Science 2013;28(3):366-373
In this study, we explored the potentiality of human arginine decarboxylase (ADC) to enhance the survival of mesenchymal stem cells (MSCs) against unfavorable milieu of host tissues as the low survival of MSCs is the issue in cell transplantation therapy. To address this, human MSCs overexpressing human ADC were treated with H2O2 and the resultant intracellular events were examined. First, we examined whether human ADC is overexpressed in human MSCs. Then, we investigated cell survival or death related events. We found that the overexpression of human ADC increases formazan production and reduces caspase 3 activation and the numbers of FITC, hoechst, or propidium iodide positive cells in human MSCs exposed to H2O2. To elucidate the factors underlying these phenomena, AKT, CREB, and BDNF were examined. We found that the overexpression of human ADC phosphorylates AKT and CREB and increases BDNF level in human MSCs exposed to H2O2. The changes of these proteins are possibly relevant to the elevation of agmatine. Collectively, our data demonstrate that the overexpression of human ADC stimulates pro-survival factors to protect human MSCs against H2O2 toxicity. In conclusion, the present findings support that ADC can enhance the survival of MSCs against hostile environment of host tissues.
Apoptosis/*drug effects
;
Brain-Derived Neurotrophic Factor/metabolism
;
Carboxy-Lyases/genetics/*metabolism
;
Caspase 3/metabolism
;
Cells, Cultured
;
Cyclic AMP Response Element-Binding Protein/metabolism
;
Humans
;
Hydrogen Peroxide/*toxicity
;
Mesenchymal Stem Cell Transplantation
;
Mesenchymal Stromal Cells/cytology/drug effects/metabolism
;
Phosphorylation
;
Proto-Oncogene Proteins c-akt/metabolism